Back to Search
CORI AGARWAL, M.D.
M.D.
Plastic Surgery Physician
NPI: 1306978960IndividualAccepts Medicare
Specialties, Licenses & Credentials
Plastic Surgery PhysicianPrimary
Plastic Surgery
Code: 208200000X
A93767(CA)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3'-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells.
PMID 17331955·Carcinogenesis·2007
8-other
Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
PMID 17341659·Carcinogenesis·2007
8-other
Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells.
PMID 17172433·Mol Cancer Ther·2006
8-other
Anti-angiogenic efficacy of grape seed extract in endothelial cells.
PMID 14767522·Oncol Rep·2004
8-other
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
PMID 14614451·Oncogene·2003
8-other
Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release.
PMID 12419835·Carcinogenesis·2002
8-other
Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
PMID 19544333·Mol Carcinog·2010
8-other
Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.
PMID 19640973·J Nutr·2009
6-review
p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.
PMID 19176374·Cancer Res·2009
7-preclinical
Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice.
PMID 19543955·Pharm Res·2009
7-preclinical
Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.
PMID 19638451·Mol Cancer Ther·2009
7-preclinical
Direct enantiomeric TLC resolution of dl-penicillamine using (R)-mandelic acid and l-tartaric acid as chiral impregnating reagents and as chiral mobile phase additive.
PMID 18651593·Biomed Chromatogr·2008
8-other
Safely navigating around the facial nerve in three dimensions.
PMID 18922299·Clin Plast Surg·2008
8-other
Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.
PMID 18644994·Mol Cancer Ther·2008
8-other
Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype.
PMID 18583941·Cell Cycle·2008
7-preclinical
Novel biomaterials in medicinal chemistry and drug discovery.
PMID 18393889·Curr Top Med Chem·2008
8-other
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice.
PMID 18445658·Mol Cancer Ther·2008
7-preclinical
Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.
PMID 18454345·Mol Cell Biochem·2008
4-observational
Grape seed extract induces cell cycle arrest and apoptosis in human colon carcinoma cells.
PMID 19003575·Nutr Cancer·2008
8-other
Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
PMID 18253818·Pharm Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- DIVISION OF PLASTIC SURGERY ADMINISTRATIVE OFFICE, 30 NORTH 1900 EAST 3B205
SALT LAKE CITY, UT 84132 - Phone
- (801) 585-6839
Quick Facts
- NPI
- 1306978960
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile